₹ 1.3 Cr
Volume Transacted
(Dec 26, 2024)
8.9 K
Stocks Traded
(Dec 26, 2024)
Last Updated on: Dec 26, 2024
Emcure Pharmaceuticals Ltd
NSE: EMCURE
Market Cap
₹ 27386.16 crore
Last updated on: Dec 26, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Market Cap of Emcure Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
No data available
* All values are consolidated
Last Updated time:
Emcure Pharmaceuticals Ltd
NSE: EMCURE
Share Price
₹ 1445.7
20.80 (1.46%)
Last updated on: Dec 26, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
26 Dec 2024 | 1445.7 | 1430 | 1463.9 | 1420.85 |
24 Dec 2024 | 1424.9 | 1370.05 | 1436.2 | 1370.05 |
23 Dec 2024 | 1386 | 1384.5 | 1392 | 1356.85 |
20 Dec 2024 | 1368.55 | 1368 | 1384.15 | 1352 |
19 Dec 2024 | 1389.1 | 1345.05 | 1402.15 | 1345.05 |
18 Dec 2024 | 1402.45 | 1390 | 1405 | 1386 |
17 Dec 2024 | 1389.6 | 1408 | 1415.95 | 1380.5 |
16 Dec 2024 | 1408.7 | 1351.7 | 1414 | 1351.7 |
13 Dec 2024 | 1359.25 | 1345.15 | 1386.05 | 1340 |
12 Dec 2024 | 1344.5 | 1350.1 | 1370 | 1337 |
Date | Price (₹) |
---|---|
26 Dec 2024 | 1445.7 |
24 Dec 2024 | 1424.9 |
23 Dec 2024 | 1386 |
20 Dec 2024 | 1368.55 |
19 Dec 2024 | 1389.1 |
18 Dec 2024 | 1402.45 |
17 Dec 2024 | 1389.6 |
16 Dec 2024 | 1408.7 |
13 Dec 2024 | 1359.25 |
12 Dec 2024 | 1344.5 |
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
No data available
No data available
No data available
No data available
Historical P/E Ratio of Emcure Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
No data available
* All values are in %
Historical Revenue of Emcure Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Emcure Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Emcure Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Emcure Pharmaceuticals announces resignation of senior management personnel
Emcure Pharmaceuticals announced that Aravamuthan Balaji, President - IT & Digital and Sen...
29 Nov 2024 19:25
Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS
Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....
22 Nov 2024 17:56
Emcure Pharma Q2 PAT rises 38.2% YoY
In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...
08 Nov 2024 12:50
Emcure Pharmaceuticals to hold board meeting
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
02 Nov 2024 13:58
Emcure Pharmaceuticals to announce Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
31 Oct 2024 10:43
Emcure signs licensing agreement with Gilead Sciences
Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...
03 Oct 2024 10:15
Unlimited trading starting at just Rs. 249*